Shankar Siva (@_shankarsiva) 's Twitter Profile
Shankar Siva

@_shankarsiva

Radiation Oncologist at the Peter MacCallum Cancer Centre @petermaccc, Professor of Medicine, University of Melbourne, Australia 🇦🇺. Views are my own. #radonc

ID: 636619613

linkhttps://www.petermac.org/expert-finder/details/shankar-siva calendar_today16-07-2012 02:03:56

6,6K Tweet

8,8K Followers

848 Following

Henning Willers, MD, FASTRO (@henningwillers) 's Twitter Profile Photo

Having a toast or two to celebrate Sophia Kamran, MD 's promotion to Associate Professor at Harvard Medical School 🥂🥳 1️⃣st ever female Assoc Prof in a GU discipline at MGH 💪🔥 #clinicianscientist #leader #teacher #mentor #multitasker👩‍🍼🐕🐕🔬🩺 #glassceilingbreaker #needherscience

Having a toast or two to celebrate <a href="/sophia_kamran/">Sophia Kamran, MD</a> 's promotion to Associate Professor at <a href="/harvardmed/">Harvard Medical School</a> 🥂🥳

1️⃣st ever female Assoc Prof in a GU discipline at MGH 💪🔥

#clinicianscientist
#leader #teacher #mentor #multitasker👩‍🍼🐕🐕🔬🩺
#glassceilingbreaker #needherscience
Giulia Marvaso (@giuliamarvaso84) 's Twitter Profile Photo

Radiotherapy is not visible enough to patients—and what they don’t see, they may fear. It’s time to strengthen patient advocacy and engagement. Let’s make RT more transparent, accessible, and empowering. prof. Barbara Jereczek-Fossa final remarks #ESTRO25 #PatientEngagement #RTAwareness

Radiotherapy is not visible enough to patients—and what they don’t see, they may fear. 
It’s time to strengthen patient advocacy and engagement. Let’s make RT more transparent, accessible, and empowering. <a href="/BarbaraJereczek/">prof. Barbara Jereczek-Fossa</a> final remarks
#ESTRO25 #PatientEngagement #RTAwareness
Peter Mac Radiation Oncology (@petermacradonc) 's Twitter Profile Photo

Congrats to Dr Neil Wallace - rising above technical challenges to deliver a fantastic presentation at #ESTRO25 on the link between functional lung #RT dosimetry and clinical toxicity in patients with #lungcancer. 👏👏👏 Well done, Neil Wallace . Peter Mac Cancer Centre ESTRO

Congrats to Dr Neil Wallace - rising above technical challenges to deliver a fantastic presentation at #ESTRO25 on the link between functional lung #RT dosimetry and clinical toxicity in patients with #lungcancer. 👏👏👏
Well done, <a href="/neildwallaceie/">Neil Wallace</a> . <a href="/PeterMacCC/">Peter Mac Cancer Centre</a> <a href="/ESTRO_RT/">ESTRO</a>
Gerry Hanna (@gerryhanna) 's Twitter Profile Photo

How did the Thora study acheive superior outcomes with higher dose RT in LS-SCLC with little increase in oesophageal toxicity? At #ESTRO25 this presentation suggests that keeping the overall treatment time short might be the key factor Should 60Gy BD over 4 weeks be a new SOC?

How did the Thora study acheive superior outcomes with higher dose RT in LS-SCLC with little increase in oesophageal toxicity?

At #ESTRO25 this presentation suggests that keeping the overall treatment time short might be the key factor 

Should 60Gy BD over 4 weeks be a new SOC?
Matthew Evison (@matthewevison1) 's Twitter Profile Photo

Published at the same time as this RCT demonstrating a reduction in pneumonitis from prehab in radiotherapy in #lungcancer. The evidence is building….. sciencedirect.com/science/articl… @btog British Thoracic Society (BTS) prehab4cancer Lung Cancer Nursing UK Lung Cancer Europe Cancer Research UK

Felipe Couñago PhD (@fcounago) 's Twitter Profile Photo

🔥⚡️🚀Great JCO editorial on the ROBOMET trial: SBRT didn’t improve pain at 1 month vs. conventional RT but showed more durable relief and a strong safety profile. Kudos to Chmiel, Matthias Guckenberger , Gillespie & Shankar Siva ! #RadiationOncology #SBRT #BoneMets OncoAlert

Hoda Abdel-Aty 💙 (@hoda_aty) 's Twitter Profile Photo

🔊 New podcast episode out now! spotifycreators-web.app.link/e/XO1wBvzSoTb Shankar Siva joins Nick James also on @Prof-Nick-James.bsky.social Hoda Abdel-Aty 💙 to discuss SABR in Renal Cell Cancers ⚡ Innovative trial design 📈 Meaningful endpoints 🩻 Response assessment and advanced imaging 🤝 Collaboration is key

Shankar Siva (@_shankarsiva) 's Twitter Profile Photo

📢This might just be THE DEFINITIVE meta-analysis of PSMA PET for #prostatecancer recurrence. 🚨Meta-analysis of 43 studies (n=8,119) ⬆️Sensitivity from 48% at PSA 0.2–0.5 ng/ml to >90% at PSA >2. Congrats Declan Murphy marlon perera + team European Association of Urology (EAU)! ➡️link shorturl.at/unfn5

📢This might just be THE DEFINITIVE meta-analysis of PSMA PET for #prostatecancer recurrence. 
🚨Meta-analysis of 43 studies (n=8,119)
⬆️Sensitivity from 48% at PSA 0.2–0.5 ng/ml to &gt;90% at PSA &gt;2. Congrats <a href="/declangmurphy/">Declan Murphy</a> <a href="/drMPerera/">marlon perera</a> + team <a href="/Uroweb/">European Association of Urology (EAU)</a>! 
➡️link shorturl.at/unfn5
Paul Sargos (@paulsargos) 's Twitter Profile Photo

☄️Neoadjuvant stereotactic ablative body radiotherapy for renal cell carcinoma (RCC) with thrombus: do, or do not? 👌Nice overview of the scarce data published by Jennifer Le Guévelou Laurence Albiges Shankar Siva and Karim Bensalah Paper online here 👇👇 sciencedirect.com/science/articl…

☄️Neoadjuvant stereotactic ablative body radiotherapy for renal cell carcinoma (RCC) with thrombus: do, or do not?

👌Nice overview of the scarce data published by 
<a href="/JennKa12/">Jennifer Le Guévelou</a>
<a href="/AlbigesL/">Laurence Albiges</a>
<a href="/_ShankarSiva/">Shankar Siva</a>
and Karim Bensalah

Paper online here 👇👇
sciencedirect.com/science/articl…